thalidomide has been researched along with cps 49 in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eger, K; Figg, WD; Gütschow, M; MacPherson, GR; Ng, SS | 1 |
| Anderson, KC; Figg, WD; Hamasaki, M; Hideshima, T; Ishitsuka, K; Kumar, S; Munshi, NC; Raje, N; Richardson, P; Roccaro, A; Shiraishi, N; Yasui, H | 1 |
| Dennis, PA; Figg, WD; Lepper, ER; Warfel, NA; Zhang, C | 1 |
| Byun, JS; De Luca, P; De Siervi, A; Figg, WD; Gardner, K; Ge, Y; Gueron, G; Haggerty, CM; Li, QQ; Quintero, J; Sadiq-Ali, SG; Yabe, IM | 1 |
| Erskine, L; Figg, WD; Gardner, ER; Therapontos, C; Vargesson, N | 1 |
| Cotignola, J; De Luca, P; De Siervi, A; Elguero, B; Figg, WD; Gardner, K; Meiss, R; Spallanzani, RG; Vallecorsa, P; Vazquez, E; Zalazar, F | 1 |
| Beedie, SL; Erskine, L; Figg, WD; Fraga, LR; Gütschow, M; Mahony, C; McMenemy, S; Rafipay, AJ; Vargesson, N | 1 |
7 other study(ies) available for thalidomide and cps 49
| Article | Year |
|---|---|
Antitumor effects of thalidomide analogs in human prostate cancer xenografts implanted in immunodeficient mice.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Enzyme-Linked Immunosorbent Assay; Humans; Immunohistochemistry; Male; Mice; Mice, SCID; Microcirculation; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Oligonucleotide Array Sequence Analysis; Platelet Endothelial Cell Adhesion Molecule-1; Platelet-Derived Growth Factor; Prostatic Neoplasms; Protein Isoforms; Receptors, Platelet-Derived Growth Factor; Signal Transduction; Thalidomide; Time Factors | 2004 |
Antimyeloma activity of two novel N-substituted and tetraflourinated thalidomide analogs.
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Apoptosis; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; DNA; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Multiple Myeloma; Stromal Cells; Thalidomide | 2005 |
Importance of the stress kinase p38alpha in mediating the direct cytotoxic effects of the thalidomide analogue, CPS49, in cancer cells and endothelial cells.
Topics: Animals; Butadienes; Cell Death; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Endothelial Cells; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Humans; Imidazoles; Mice; Mice, SCID; Mitogen-Activated Protein Kinase 14; Neoplasms; Nitriles; Pyridines; Structure-Activity Relationship; Thalidomide; Xenograft Model Antitumor Assays | 2006 |
Combinatorial antileukemic disruption of oxidative homeostasis and mitochondrial stability by the redox reactive thalidomide 2-(2,4-difluoro-phenyl)-4,5,6,7-tetrafluoro-1H-isoindole-1,3(2H)-dione (CPS49) and flavopiridol.
Topics: Antineoplastic Agents; Apoptosis Regulatory Proteins; Cell Death; Cell Line, Tumor; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Flavonoids; Free Radical Scavengers; Glutathione; Homeostasis; Humans; Intracellular Space; Leukemia; Membrane Potential, Mitochondrial; Mitochondria; NF-kappa B; Nuclear Proteins; Organ Specificity; Oxidation-Reduction; Piperidines; Proto-Oncogene Proteins; Reactive Oxygen Species; Thalidomide; Transcription, Genetic; Tumor Suppressor Proteins | 2008 |
Thalidomide induces limb defects by preventing angiogenic outgrowth during early limb formation.
Topics: Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Chick Embryo; Cytoskeleton; Humans; Inflammation Mediators; Limb Deformities, Congenital; Neovascularization, Physiologic; Pseudopodia; Signal Transduction; Thalidomide; Time Factors | 2009 |
Low doses of CPS49 and flavopiridol combination as potential treatment for advanced prostate cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Drug Combinations; Flavonoids; Humans; Male; Mice; Mice, Nude; Piperidines; Prostatic Neoplasms; Thalidomide; Treatment Outcome | 2015 |
CPS49-induced neurotoxicity does not cause limb patterning anomalies in developing chicken embryos.
Topics: Angiogenesis Inhibitors; Animals; Body Patterning; Bungarotoxins; Chick Embryo; Embryonic Development; Extremities; Female; Limb Buds; Limb Deformities, Congenital; Mice; Mice, Inbred C57BL; Neuronal Outgrowth; Neurotoxicity Syndromes; Teratogens; Thalidomide | 2018 |